References
- 1
Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M. et al .
The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Pharmacopsychiatry.
2004;
37
243-265
- 2
Chan WK, Nguyen LT, Miller VP, Harris RZ.
Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and
red wine.
Life Sci.
1998;
62
135-142
- 3
DeVane CL, Nemeroff CB.
Clinical pharmacokinetics of quetiapine: an atypical antipsychotic.
Clin Pharmacokinet.
2001;
40
509-522
- 4
Frahnert C, Rao ML, Grasmader K.
Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites
in serum by liquid chromatography: a simple tool for therapeutic drug monitoring.
J Chromatogr B Analyt Technol Biomed Life Sci.
2003;
794
35-47
- 5
Gerlach M, Hunnerkopf R, Rothenhofer S, Libal G, Burger R, Clement HW. et al .
Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.
Pharmacopsychiatry.
2007;
40
72-76
- 6
Grimm SW, Richtand NM, Winter HR, Stams KR, Reele SB.
Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine
pharmacokinetics.
Br J Clin Pharmacol.
2006;
61
58-69
- 7
Hiemke C, Dragicevic A, Grunder G, Hatter S, Sachse J, Vernaleken I. et al .
Therapeutic monitoring of new antipsychotic drugs.
Ther Drug Monit.
2004;
26
156-160
- 8
Pessina A, Turlizzi E, Bonomi A, Guizzardi F, Cavicchini L, Croera C. et al .
In vitro toxicity of clozapine, olanzapine, and quetiapine on granulocyte-macrophage
progenitors (GM-CFU).
Pharmacopsychiatry.
2006;
39
20-22
- 9
Polasek TM, Miners JO.
Quantitative prediction of macrolide drug-drug interaction potential from in vitro
studies using testosterone as the human cytochrome P4503A substrate.
Eur J Clin Pharmacol.
2006;
62
203-208
- 10
Quinney SK, Haehner BD, Rhoades MB, Lin Z, Gorski JC, Hall SD.
Interaction between midazolam and clarithromycin in the elderly.
Br J Clin Pharmacol.
2008;
65
98-109
- 11
Spina E, Leon J de.
Metabolic drug interactions with newer antipsychotics: a comparative review.
Basic Clin Pharmacol Toxicol.
2007;
100
4-22
- 12
Thyrum PT, Wong YW, Yeh C.
Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment.
Prog Neuropsychopharmacol Biol Psychiatry.
2000;
24
521-533
Correspondence
M. UferMD, PhD
Institute of Pharmacology
University Hospital Schleswig-Holstein
Hospitalstr. 4
24105 Kiel
Germany
Telefon: +49/431/597 36 95
Fax: +49/431/597 35 22
eMail: mikeufer@gmx.de
